Zeugma Hyperbaric Chamber Price: 2026 Cost Breakdown and Buying Guide

A futuristic white pod with a glowing blue interior housing a reclining seat, related to zeugma hyperbaric chamber price.

Affiliate Disclosure

This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. This does not influence our evaluations or rankings.


How we evaluate: Our recommendations are based on published clinical evidence, manufacturer specifications, and real user feedback. We may earn a commission if you purchase through our links, at no extra cost to you. This does not influence our rankings.
Full disclosure.

The Zeugma hyperbaric chamber is manufactured by HPO Tech in Turkey and targets clinical and premium wellness markets. Pricing is not publicly listed by the manufacturer; prospective buyers obtain quotes via HPO Tech’s online cost calculator or through US distributor Atlanta Hyperbaric Center. Based on comparable monoplace clinical chambers, the Zeugma likely ranges from $40,000-$80,000+, depending on pressure variant, optional certifications, and customizations.12

What Is the Zeugma Hyperbaric Chamber?

The Zeugma is a monoplace hard-shell hyperbaric chamber made by HPO Tech, a Turkish medical device manufacturer. It is distinct from most hard-shell chambers in that it spans four pressure variants (1.5, 2.0, 2.4, and 3.0 ATA) in a single product line, bridging the gap between premium wellness and clinical medicine. HPO Tech emphasizes aerospace-grade aluminum construction and extensive customization options including 170+ RAL color codes.1

Zeugma Pricing: What to Expect

HPO Tech does not publish the Zeugma price list publicly. Pricing depends on:

  • Pressure variant selected (1.5, 2.0, 2.4, or 3.0 ATA)
  • Optional certifications (Medical CE, ASME PVHO-1, UKCA)
  • Customization (color, finish, accessories)
  • Volume or distribution agreements
  • Import and shipping costs (Turkey to US)

Based on publicly available pricing for comparable monoplace clinical chambers, the Zeugma estimated range is $40,000-$80,000+ for the unit alone. US purchasers should factor in import duties, shipping, and installation.

Comparable Product Manufacturer Price Max ATA
Macy-Pan HP2202 Macy-Pan (China) $40,500 2.0 ATA
OxyRevo Space60 OxyRevo $42,999 2.0 ATA
Airvida Elite Airvida $45,999 2.0 ATA
Macy-Pan HE5000 Macy-Pan (China) $61,500 2.0 ATA multiplace
Sechrist monoplace Sechrist (USA) $75,000-$200,000 3.0 ATA
Perry Baromedical Perry (USA) $100,000-$500,000+ 6.0 ATA
1.5-3.0 ATAFull pressure range available in the Zeugma product line from a single manufacturer, unique in the marketHPO Tech product specifications, 2026

The 6 Key Factors That Affect Zeugma Pricing

1. Pressure Variant

The 1.5 ATA model is the entry point and targets premium wellness applications. The 2.0 and 2.4 ATA models serve clinical operators treating wound care and other indications. The 3.0 ATA variant reaches the upper range for clinical hyperbaric medicine. Higher pressure variants require more robust pressure vessel engineering and carry higher base costs.

2. Medical CE Certification

Standard CE certification is included. Medical CE (EU Medical Device Regulation 2017/745) is available as an optional upgrade. Medical CE requires more extensive clinical documentation and quality management compliance. This option is important for operators making specific medical claims or operating in EU markets.

3. ASME PVHO-1 Certification

ASME PVHO-1 (Pressure Vessels for Human Occupancy) is the engineering standard for hyperbaric chamber construction. It is voluntary but widely considered the gold standard for pressure vessel safety. Zeugma offers this as an optional certification. US clinical operators typically require it.

4. UKCA Certification

Required for UK market sales post-Brexit. Irrelevant for US buyers but adds cost if required by an operator selling into UK markets.

5. Customization

HPO Tech offers 170+ RAL color codes, which differentiates the Zeugma in premium wellness settings where aesthetics matter. Custom color increases lead time and potentially unit cost.

6. Import and Installation

Shipping from Turkey to the US, import duties, and professional installation add $5,000-$15,000+ to the base unit price for US buyers.

“The Zeugma is the only chamber line spanning 1.5 to 3.0 ATA from a single manufacturer with optional ASME PVHO-1 and Medical CE certification. It bridges the gap between consumer wellness and clinical medicine.”
BaricBoost equipment analysis, 2026

FDA Clearance Status

The Zeugma holds CE certification but not FDA 510(k) clearance. This is important for US clinical operators: the Zeugma cannot be marketed as an FDA-cleared medical device for specific therapeutic claims. Perry Baromedical and Sechrist Industries are the leading FDA-registered manufacturers of clinical chambers in the US. However, CE certification with optional Medical CE and ASME PVHO-1 provides comparable rigor for international and some US wellness facility applications.3

How to Get a Zeugma Quote

HPO Tech provides a cost calculator at hpotech.com for prospective buyers. US buyers can also contact Atlanta Hyperbaric Center, which carries the Zeugma in its North American product lineup. Expect a 4-8 week lead time for quotes on custom-specification units.

  1. HPO Tech. “Cost Calculator – Hyperbaric Chamber Price.” hpotech.com. Accessed May 2026.
  2. Atlanta Hyperbaric Center. “ZEUGMA Monoplace Wellness Hyperbaric Chamber.” atlantahyperbariccenter.com. Accessed May 2026.
  3. FDA 510(k) Database. accessdata.fda.gov. Accessed May 2026.
  4. Airvida Chambers. “Hyperbaric Chamber Cost & Price Guide.” airvidachambers.com. 2025.
  5. Warrior Willpower. “Hyperbaric Chamber Cost.” warriorwillpower.com. 2025.
  6. ASME. “PVHO-1 Safety Standard for Pressure Vessels for Human Occupancy.” asme.org.

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Why Trust Our Evaluations

Our rankings are based on hands-on testing, published clinical data, and verified manufacturer specifications. We apply the same criteria to every product regardless of affiliate status. Editorial Process · Evaluation Methodology

Previous Article

Alibaba Hyperbaric Chamber: Complete Smart Buying Guide for 2025

Next Article

The Complete Guide to Using a Pet Hyperbaric Oxygen Chamber for Recovery

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide